chrisvoncsefalvay/vaers-outcomes huggingface dataset:
hand shaking; can't sleep; lays bed most of the day and is confused; Panic attack; has no energy; she is tired; has chills; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of NERVOUSNESS (hand shaking), INSOMNIA (can't sleep), CONFUSIONAL STATE (lays bed most of the day and is confused), PANIC ATTACK (Panic attack) and ASTHENIA (has no energy) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 05BF21A, 010A21A and 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NERVOUSNESS (hand shaking), INSOMNIA (can't sleep), CONFUSIONAL STATE (lays bed most of the day and is confused), PANIC ATTACK (Panic attack), ASTHENIA (has no energy), FATIGUE (she is tired), CHILLS (has chills) and ARTHRALGIA (joint pain). At the time of the report, NERVOUSNESS (hand shaking), INSOMNIA (can't sleep), CONFUSIONAL STATE (lays bed most of the day and is confused), PANIC ATTACK (Panic attack), ASTHENIA (has no energy), FATIGUE (she is tired), CHILLS (has chills) and ARTHRALGIA (joint pain) outcome was unknown.            No concomitant medications were provided. Patient reported that her doctor gave her a medicine for panic attacks, but her doctor did not know what was wrong. Patient went to ER 3-4 times   This case was linked to MOD-2022-467151 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 01-Feb-2022: Significant Followup received on 01-FEB-2022 includes Dose 1 and Dose 2 information like drug start date and LOT no. is updated. Secondary Reporter is also added (consumer). Address of primary reporter is updated. Pregnancy status of patient is updated as No.
Swollen eyes and blotchy all over body. Tx with Benadryl and Tylenol CB if NB.
Information has been received from a health professional concerning a 15 year old female who on approximately 09-FEB-2008 was vaccinated with her third dose of GARDASIL and experienced syncope.  Subsequently the patient experienced no previous event after receiving the first or second dose of the series.  The patient sought unspecified medical treatment.  Subsequently, the patient recovered from syncope.  Additional information has been requested. Follow-up received 07/11/2008. The patient was reclined and cold compresses were supplied. Subsequently, the patient recovered from syncope. Additional information has been requested.
Pt reports rash started 3/20/21 . pt  s/p  Pfizer covid 19 vaccine #1  at hospital.  2nd dose  of pfizer covid 19 vaccine was given 3/25/21. pt was also on IV antibiotics then, for MMSA, possible endocarditis-  intolerante of ceftaroline, had anemia on linezolid. see HOSPITAL notes for treatment course  has been on antibiotics since 11/2020. Pt s/p powerline removal by IR 4/9/21 at VA. Pt was to have explanation of  AICD for presumed infection but then presented to GNV ED 3/30/21 for rash x  10 days which ID felt was most likely drug reaction from Ceftaroline.  (intolerant to doxy, linezolid) completed 3 mos IV antibiotics.  Last dose of ceftaroline was 3/29/21 Received Pfizer dose #1 3/4/21 and dose #
Patient received PNEUMOVAX and flu on 10-20-2010. The arm she got the pneumonia vaccine in was reported as red, swollen & painful on 10-21-10. Had similar symptoms 5 yrs ago with previous pneumonia vaccine.
Moderna COVID-19 Vaccine EUA  Fever noted approximately 24 hours after vaccine (101 degrees at 8:00 on 12.Jan) Chills, tiredness, slight headache, joint pain (knees, hips, ankles, shoulders, fingers) Took Aleve for pain Fever was 101.5 at 7PM; took Advil/Tylenol Fever broke around 9PM (98.6)
Patient states she had left shoulder/arm pain after administration of her flu vaccine on 09/24/18. She states that she felt pressure in her left shoulder joint with the administration of the vaccine. She rates the left shoulder discomfort 6/10 aching, stabbing, burning with certain movements. She denied any numbness, tingling or weakness in the LUE. No erythema, edema, streaking in the LUE. No cervical spine tenderness. Full ROM of the left shoulder joint with minimal discomfort on initial evaluation 10-11-18 at office. No neurovascular deficits.
Day 16 post vaccine: significant top of foot/ankle edema with pitting edema also minor swelling up to groin (~1cm larger compared to right up the leg).  Right lower leg and F&A also had minor pitting, but not the pronounced swelling seen in the left.    Did self MLD massage, elevated and wore compression.  Tingling in left leg overnight and felt heavy.   Called doctor's office as soon as they opened on Day 17 post.  Saw them that afternoon.  Swelling had already gone down significantly either on its own or due to compression, elevation, and massage.   Practitioner noted pitting edema in both ankles, more pronounced in left.  It was not painful or warm, so she ordered a D-dimer test if I still had swelling over the weekend.   Since swelling continued to improve, nothing else was done.
Breakthrough COVID.  First vaccine 3/16/2021.  Pt reports he was sitting on a cardboard box containing toilet paper with his fabric mask on, playing with his phone, waiting to clock out of work.  Then suddenly patient loses consciousness and next thing he knows he is on the floor near a spray bottle, which contained a strong chemical. Pt noted he was drenched with the chemical. He endorses the spray bottle, which was stored next to the box, to his knowledge was closed. Patient also reports he did not use the chemical that day.  After he recovered his consciousness, he was confused and he could not feel his right hand in noted blurry vision,  both which rsolved after he was in the ED.
little headache; Initial information was received on 03-Aug-2023 regarding an unsolicited valid non-serious case received from a consumer/non-health-care professional.  This case involves 16 years old male patient who experienced little headache after receiving meningococcal a-c-y-w135 (d conj) vaccine [Menactra].  The patient's past medical history included Crying, General body pain, Vomiting with migraine is so intense, Flu with gotten flu 4 or 5 times, Streptococcal infection, Feverish and Exhaustion. The patient's past medical treatment(s), vaccination(s) and family history were not provided. At the time of the event, the patient had ongoing Migraine.  On an unknown date in 2017, the patient received a unknown dose of suspect meningococcal a-c-y-w135 (d conj) vaccine (Solution for injection) (strength, expiry date, lot number not reported) via unknown route in unknown administration site for Immunization. The information on batch number was requested.  On an unknown date the patient developed a non-serious event of little headache (unknown latency) following the administration of meningococcal a-c-y-w135 (d conj) vaccine.  Relevant laboratory test results included: Body temperature - On an unknown date: [high fevers]  Action taken with meningococcal vaccine (Menactra) was not applicable.  It was not reported if the patient received a corrective treatment for the event (little headache).  At time of reporting, the outcome was Recovered on an unknown date for the event little headache.
Information has been received from a health professional concerning a patient in second grade who was vaccinated with a dose of Varivax. Subsequently the patient experienced chickenpox. Additional information has been requested.
not so bad pain full but not long; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain. On an unknown date, the outcome of the pain was unknown.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.  Additional information provided were as follows: The case was reported for the mother. Age at vaccination was not reported. The reporter reported that he/she don't like anything injected in body. The reporter reported that her mother friend also had bad pain but not so long. Note: No additional case was created for mother's friend as the vaccine received by her was unspecified.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR081910:same reporter
Subsequent to receiving one dose of varicella virus vaccine live the pt was exposed to varicella. One week post exposure the pt experienced full blown chickenpox with diffuse rash, mild fever, and irritability. Four other pts were reported with chickenpox following vaccination with varicella virus vaccine live. Follow up information indicated the physician knew nothing of these pts. Further follow up indicated the pt recovered.
No additional adverse effects reported; improperly stored doses of MMRII and VARIVAX; This spontaneous report has been received from an administrator reporting on a patient of unknown age and gender. There was no information about the patient's concurrent conditions, medical history or concomitant medication.  On 01-JUN-2020, the patient was vaccinated with an improperly stored dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live recombinant Human albumin (rHA) (M-M-R II) for prophylaxis lot number S014430  and expiration date 09-MAY-2021 (dose and route of administration were not reported) and varicella virus vaccine live (Oka/Merck) (VARIVAX) for prophylaxis lot number S032354 and expiration date 14-OCT-2021 (dose and route of administration were not reported). No additional adverse effects reported.  It was reported that on an unspecified date, the vaccines were exposed to an unspecified temperature for 20 hours. The reporter stated that there was no previous temperature excursion. The call was not placed because of a Digital Data logger report.
Patient received FLUZONE PF (preservative-free, prefilled syringe) at approximately 11:13 am on 10/9/10. At 4:07pm 10/10/10 she reported fatigue and fever of 101.4 degrees F. She was advised to call her doctor immediately or seek emergency care.
Hives.  Vitals checked and BP 134/78, pulse 95, SPO2 99.  Lungs clear. hives noted on posterior neck, back, upper arms, thighs.  Patient given 50mg Benadryl at 630pm.  Monitored x 1 hour.  Improved.  Sent home with scheduled benadryl.  Patient already has EpiPen on hand.  Instructed to follow-up with PCP.
Severe arm pain from shoulder through fingers. Arm numbness. Pain worsens with movement.
On and off neuropathy in hands and feet; Right ear sensitivity / "popping", like with changing air pressure,; Slight woozy/dizziness; Injection site soreness; tingly outside of left arm / left pinky; Very mild headache; tiredness; Stiff / sore neck (including upper shoulder area) Left side of left arm and leg including hand; sore neck (including upper shoulder area) Left side of left arm and leg including hand; sore neck (including upper shoulder area) Left side of left arm and leg including hand; slight numbness/ Slight numbness in pinky fingers on both hands, and left toes; General "not feeling good"; nausea; This is a spontaneous report from a contactable consumer (patient). A 28-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), at same age, via an unspecified route of administration, administered in Arm Left on 06Apr2021 10:45 (Batch/Lot Number: EW0162) as single dose for covid-19 immunisation. Medical history included developmental trauma disorder, drug allergy, allergies certain adhesives, borderline personality disorder, and irritable bowel syndrome. Patient is not pregnant at time of vaccination. The patient's concomitant medications were not reported.  The patient experienced very mild headache, and mild tiredness were on 06Apr2021. On 07Apr2021 (day 2), patient was experienced injection site soreness, tingly outside of left arm/ left pinky. During day 6-7 (in Apr2021), patient experienced headache, stiff / sore neck (including upper shoulder area) left side of left arm and leg including hand and foot, tingly and slight numbness, general "not feeling good", slight nausea/ need to lie down, but not fatigue / wooziness. No fever. On 13Apr2021 (day 8), patient experienced slight woozy/dizziness, in waves. Slight numbness in pinky fingers on both hands, and left toes. On 14Apr2021 (day 9), on and off neuropathy in hands and feet, specifically left leg from knee down (outside of left toes and bottom of left foot) and pinky fingers, most notably when falling asleep/ waking up, or after being on my feet for a while. Right ear sensitivity/ "popping", like with changing air pressure, but on and off (most likely unrelated, but during same period). Adverse event result in doctor or other healthcare professional office/clinic visit. No treatment for events. The patient underwent lab tests and procedures which included saliva test: negative on 13Apr2021. The outcomes of events were unknown.
This case was received from a health professional on 20 April 2009. It is part of a cluster of five patients who experienced events following Tubersol administration; the other four patients are captured in case numbers 2009-01674 (1 patient), 2009-01673 (1 patient), and 2009-01672 (2 patients). A patient received an intradermal injection of Tubersol (lot number C3062AA) in April 2009. Two hours post-vaccination, the patient developed an itchy arm and fine rash from wrist to elbow. The patient was seen in the emergency department, and treated with steroid, ZANTAC and BENADRYL. The outcome was reported as "recovered". Follow-up information was received from a different health care professional at the same facility on 21 April 2009. The patient received the Tubersol 5U on 20 April 2009. Additional symptoms included shortness of breath, increased blood pressure, palpitations, and itching all over body. The patient also had an injection site induration of > 50mm. It was noted that the patient had been receiving PPD tests for 20 years. Follow-up information was received 01 June 2009 from a health care professional. The patient was identified as a 25-year-old female. The reporter also provided identifying information for the two previously unidentified patients in case 2009-01762 who had received Tubersol, lot number C3149AA. Case 2009-01762 will remain the case of reference for one patient and the other patient has been captured in case 2009-02323.Follow-up information was received from a health care professional on 22 June 2009. The patient also received a third right deltoid intramuscular injection of hepatitis B vaccine (Merck, lot number AHBUN608AA) on April 2009. The patient had not been receiving PPD tests for 20 years, and did not have any injection site induration. Concomitant medications and medical history were unknown; it was also unknown whether treatment medications had been administered orally or intravenously. The PPD was administered at 8:15 am, and events occurred at 10:30 am. The final diagnosis was "allergic reaction to PPD," and no allergy testing was scheduled. The events recovered on an unknown date. Documents held by sender: none.
5:00 pm my left arm became very sore to raise or move. It felt like some had punched my shoulder and it was dead weight, my left armpit was also very sore even to touch. I took Tylenol 500mg 2 tabs po at 9 pm due to the pain.
Patient with small cell carcitoma 2001.  Chemotherapy 2001, radiation 2001.  Pneumovax 23/Pneumoimmune 23 given 07/17.  Guillian Barre syndrome developed 4 days later 2003.  Requiring 1 week in hospital, 1 week in rehab cenber.  On going recovery.
I tested started feeling bad on 05/01/2022 and I did at test and get was positive on 05/02/2022. I also did a PCR test with facility. My symptoms are moderate, I have a bad cold, low grade fever 101.1, sore throat, running nose, running eyes, sneezing and chills. I did a at home COVID test and it was positive and then I did a PCR test and I am waiting on the results for it. I have been quarantine for about 3 days.
blood transfusion; Hemoglobin dropped from 12 to 6; Feeling unwell; anemia; This spontaneous case was reported by a consumer and describes the occurrence of TRANSFUSION (blood transfusion), HAEMOGLOBIN DECREASED (Hemoglobin dropped from 12 to 6), MALAISE (Feeling unwell) and ANAEMIA (anemia) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     Concomitant products included LOSARTAN, OMEPRAZOLE (PROTONIX [OMEPRAZOLE]) and LAMOTRIGINE (LAMICTAL) for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TRANSFUSION (blood transfusion) (seriousness criterion hospitalization), HAEMOGLOBIN DECREASED (Hemoglobin dropped from 12 to 6) (seriousness criterion hospitalization), MALAISE (Feeling unwell) (seriousness criterion hospitalization) and ANAEMIA (anemia) (seriousness criterion hospitalization). At the time of the report, TRANSFUSION (blood transfusion), HAEMOGLOBIN DECREASED (Hemoglobin dropped from 12 to 6), MALAISE (Feeling unwell) and ANAEMIA (anemia) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reportedly, patient's hemoglobin dropped from 12 to 6 after receiving her first dose of the Moderna COVID-19 vaccine on 03-March- 2021. Patient said about a week and half after receiving the vaccine, she was not feeling well. She is anemic. Two weeks prior to receiving the vaccine, her blood work showed her hemoglobin was 12. According to reporter two weeks after receiving the vaccine, she received a call and she was asked to go to the emergence room since her labs was showing her hemoglobin has dropped to 6. She went to the emergency room and she received blood transfusion. Patient said she went to the hospital maybe on the 14-Mar-2021 and she was in the emergency room for two days. At the time of the call, patient confirmed that she was doing fine and her hemoglobin was back to 12 which was her normal. According to the patient her doctors said they do not think this is from the vaccine.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Fever of 101- 102 for 36 hrs Burning stiff joints - ankles, knees, wrists Fingers were  stiff  Tired slept for 2 days severe headache  Treated with Tylenol - keep the fever down,  had no affect on joints Took Excedrin for headache- that made the headache 75% better
Patient described hives located on back, face, chest and abdomen 18 hours after receiving vaccine. The site where received was warm, red and induration about 48 hours. Took Benadryl.
Patient came into clinic for his shingles vaccine, noting that it would be his dose to finish the series. Medical assistant printed off the records and verified that he had completed this in 2019 with a series of two shots. Then verified with the medical professional here in clinic. She checked record and stated to administer with the shot, however she had the misunderstanding and over read the patients record and thought he had a zostavax first, and then one shingrix so with that she had medical assistant administer what she thought would of been the second shingrix.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided) on an unknown date in 2016, for routine health maintenance and for the prevention of shingles. On an unknown date after receiving the ZOSTAVAX, the patient began to experience facial drooping. In response to these complaints, the patient presented to an emergency room and was diagnosed as suffering from Bell's palsy (outcome unknown). The patient later suffered from the inability to close her left eye. In response to this complaint, on an unknown date, the patient presented to her primary care physician and was diagnosed with lagophthalmos, which required surgery to correct. Because of ZOSTAVAX, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Upon internal review, Bell's palsy was determined to be medically significant. Additional information has been requested.
Associate had a needlestick injury while giving this flu shot due to a defective needle safety device.
been vaccinated and had shingles/Suspected vaccination failure; pneumonia; shingles; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), pneumonia (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and pneumonia were unknown and the outcome of the shingles was recovered/resolved.   It was unknown if the reporter considered the vaccination failure, pneumonia and shingles to be related to Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient had been vaccinated and had shingles twice been sick with pneumonia and had shingles now. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation for shingles were unknown at the time of reporting.
Pt presented to ER 1 hour after receipt of 2nd Pfizer vaccine, presenting with angioedema/anaphylaxis,  In ER received epi, racemic epi, solumedrol, mamotidine, benadryl, then intubated and moved to ICU. Was hemodynamically stable, unremarkable airway pressures.